Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Angle Plc ADR (ANPCY)

Angle Plc ADR (ANPCY)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2000 +0.1450 (+13.74%) 03/27/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 1.2000 unch (unch) 12:39 ET
Quote Overview for Thu, Mar 27th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2000
Day High
1.2000
Open 1.2000
Previous Close 1.0550 1.0550
Volume 400 400
Avg Vol 930 930
Stochastic %K 10.96% 10.96%
Weighted Alpha N/A N/A
5-Day Change +0.0065 (+0.54%) +0.0065 (+0.54%)
52-Week Range 0.7362 - 3.3500 0.7362 - 3.3500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9450 +26.98%
on 03/17/25
Period Open: 1.8465
1.7400 -31.03%
on 03/06/25
-0.6465 (-35.01%)
since 02/07/25
3-Month
0.9450 +26.98%
on 03/17/25
Period Open: 1.3500
2.3900 -49.79%
on 02/04/25
-0.1500 (-11.11%)
since 12/18/24
52-Week
0.7362 +63.00%
on 10/25/24
Period Open: 1.8000
3.3500 -64.18%
on 05/15/24
-0.6000 (-33.33%)
since 03/12/24

Most Recent Stories

More News
Angle PLC Announces Issue of LTIP Options and Share Options

GUILDFORD, SURREY / ACCESS Newswire / March 21, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, under the Remuneration Policy approved by the shareholders...

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
Angle PLC Announces Results of Eisai Phase 2 pilot study

UPDATE ON ASTRAZENECA ASSAY DEVELOPMENT PROJECTS AND SUCCESSFUL COMPLETION OF EISAI CONTRACT

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay

NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich

CLINICAL TRIAL POWERED BY PARSORTIX SYSTEM PROVIDES FIRST-IN-CLASS data FOR NOVEL APPROACH TO CANCER treatment

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
Angle PLC Announces Trading Update

Revenue for 2024 expected to be up 31%

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
Angle PLC Announces HER2 Presentation at SABCS

WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
ANGLE presents two posters at EACR

PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCE

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
Angle PLC Announces Publication Demonstrates CTC Profiling Potential

PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCER

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)
Angle PLC Announces Result of 2022 Annual General Meeting

GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...

ANPCY : 1.2000 (+13.74%)
AGL : 4.49 (-2.60%)

Business Summary

ANGLE PLC was incorporated on December 04, 2003 in England and Wales. It is a commercially driven specialist medical diagnostic company with products in cancer diagnostics and foetal health. The Company is commercializing a platform technology that can capture cells circulating in blood, such as cancer...

See More

Key Turning Points

3rd Resistance Point 1.2000
2nd Resistance Point 1.2000
1st Resistance Point 1.2000
Last Price 1.2000
1st Support Level 1.2000
2nd Support Level 1.2000
3rd Support Level 1.2000

See More

52-Week High 3.3500
Fibonacci 61.8% 2.3515
Fibonacci 50% 2.0431
Fibonacci 38.2% 1.7347
Last Price 1.2000
52-Week Low 0.7362

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies